Atlas Trials

A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors

Clinical trial NCT05956587 · RECRUITING

Trial details

NCT number
NCT05956587
Sponsor
Sichuan Baili Pharmaceutical Co., Ltd.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung CancerNasopharyngeal Carcinoma
Start date
2024-01-29
Primary completion
2026-12-01
Enrollment
121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.